Crossing boundaries

Prime brokers are expanding cross-margining facilities to include ever-more exotic products as a means of reducing margin for hedge fund clients. Dealers say the reductions are justified from a risk management perspective, but regulators continue to have misgivings. By John Ferry

pg31-gif

Regulators in the US have issued a string of warnings over the past year about the dangers of prime brokers over-aggressively slicing margin requirements for their hedge fund clients. In March, Annette Nazareth, a commissioner at the US Securities and Exchange Commission (SEC), said there was a need for adequate margin requirements to withstand periods of systematic stress. Then, in May, Timothy Geithner, president of the Federal Reserve Bank of New York, called for major dealers to take a "cold

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Credit risk & modelling – Special report 2021

This Risk special report provides an insight on the challenges facing banks in measuring and mitigating credit risk in the current environment, and the strategies they are deploying to adapt to a more stringent regulatory approach.

The wild world of credit models

The Covid-19 pandemic has induced a kind of schizophrenia in loan-loss models. When the pandemic hit, banks overprovisioned for credit losses on the assumption that the economy would head south. But when government stimulus packages put wads of cash in…

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here